Using artificial intelligence to accelerate cell and gene therapies
"We are not made of drugs, we are made of cells". By Cade Hildreth,the Founder of BioInformant.com, the world's largest publisher of stem cell industry news
Cell and Gene Therapy
According to an article published last year by McKinsey (“How AI can accelerate R&D for cell and gene therapies”), within oncology the cell therapy 🧫 modality is expected to become the third-largest segment across all therapies (behind antibodies and small molecules) by 203…